GS-9695

CAS No. 1471256-08-2

GS-9695( GS9695 | GS 9695 )

Catalog No. M12018 CAS No. 1471256-08-2

GS-9695 is a potent, non-catalytic site HIV integrase inhibitor with wild type EC50 of 1.2 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GS-9695
  • Note
    Research use only, not for human use.
  • Brief Description
    GS-9695 is a potent, non-catalytic site HIV integrase inhibitor with wild type EC50 of 1.2 nM.
  • Description
    GS-9695 is a potent, non-catalytic site HIV integrase inhibitor with wild type EC50 of 1.2 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GS9695 | GS 9695
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1471256-08-2
  • Formula Weight
    594.171
  • Molecular Formula
    C31H36ClN5O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    (S)-2-(tert-butoxy)-2-(7-(4-chlorophenyl)-2-(6-(4-isopropylpiperazin-1-yl)pyrazin-2-yl)-5-methylbenzo[d]thiazol-6-yl)acetic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • PD 404182

    PD 404182 (PD404182, PD-404182) is a heterocyclic iminobenzothiazine derivative with antimicrobial and anti-inflammatory properties, a potent inhibitor of human DDAH1 activity (IC50=9 uM) and elevates cellular ADMA levels.

  • 14-Dicaffeoylquinic ...

    14-Dicaffeoylquinic acid has antioxidant activity.14-Dicaffeoylquinic acid is a potent and highly selective class of HIV-1 integrase inhibitors inhibitsHIV-1 replication in MT-2 cell culture at non-toxic concentrations.

  • Tenofovir alafenamid...

    Tenofovir alafenamide fumarate (TAF) is an oral phosphonoamidate prodrug of the HIV reverse transcriptase nucleotide inhibitor tenofovir (TFV).